ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Accustem Sciences Inc (QB)

Accustem Sciences Inc (QB) (ACUT)

0.37
0.00
(0.00%)
Closed March 28 04:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.37
Bid
0.367
Ask
0.50
Volume
79
0.00 Day's Range 0.00
0.3602 52 Week Range 1.95
Market Cap
Previous Close
0.37
Open
-
Last Trade
1
@
0.4071
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,572
Shares Outstanding
11,346,535
Dividend Yield
-
PE Ratio
-1.12
Earnings Per Share (EPS)
-0.33
Revenue
-
Net Profit
-3.75M

About Accustem Sciences Inc (QB)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Newark, Delaware, USA
Founded
1970
Accustem Sciences Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ACUT. The last closing price for Accustem Sciences (QB) was $0.37. Over the last year, Accustem Sciences (QB) shares have traded in a share price range of $ 0.3602 to $ 1.95.

Accustem Sciences (QB) currently has 11,346,535 shares outstanding. The market capitalization of Accustem Sciences (QB) is $4.20 million. Accustem Sciences (QB) has a price to earnings ratio (PE ratio) of -1.12.

ACUT Latest News

AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership

    AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership   London, UK and Phoenix, AZ -- July 17...

AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer

 AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00982.720710716270.36020.410.36024110.36640057CS
4-0.0811-17.9782753270.45110.599450.360216240.45385891CS
12-0.28065-43.13378928760.650650.72460.360235720.53439974CS
26-0.5135-58.12110922470.88350.88350.360223360.57230679CS
52-0.4492-54.8339843750.81921.950.360241541.11593811CS
156-1.28-77.57575757581.6530.26143121.03226721CS
260-1.28-77.57575757581.6530.26143121.03226721CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 17.48
(268.00%)
410.75k
BCGBinah Capital Group Inc
$ 19.10
(101.05%)
128.02k
PIKKidpik Corporation
$ 5.60
(71.25%)
1.2M
SSKNStrata Skin Sciences Inc
$ 0.66
(48.35%)
2
PEGRProject Energy Reimagined Acquisition Corporation
$ 11.58
(33.72%)
314
NCNANuCana PLC
$ 0.2405
(-21.57%)
31.37k
WAVDWaveDancer Inc
$ 2.93
(-18.61%)
10
UGROUrban Gro Inc
$ 1.48
(-18.46%)
393
INOInovio Pharmaceuticals Inc New
$ 10.65
(-18.27%)
33
SOBRSOBR Safe Inc
$ 0.41
(-18.00%)
1.49k
KTRAKintara Therapeutics Inc
$ 0.1183
(32.18%)
10.2M
AKBAAkebia Therapeutics Inc
$ 2.61
(16.52%)
2.42M
GMDAGamida Cell Ltd
$ 0.0489
(-17.40%)
1.46M
CISSC3is Inc
$ 0.0357
(-6.54%)
1.38M
PIKKidpik Corporation
$ 5.57
(70.34%)
1.2M

ACUT Discussion

View Posts

Your Recent History

Delayed Upgrade Clock